Urology
Volume 76, Issue 1 , Pages 9-13 , July 2010

Ketorolac is Underutilized After Ureteral Reimplantation Despite Reduced Hospital Cost and Reduced Length of Stay

  • Jonathan C. Routh

      Affiliations

    • Department of Urology, Children's Hospital Boston, Boston, Massachusetts
    • Harvard Pediatric Health Services Research Fellowship Program, Harvard Medical School, Boston, Massachusetts
    • ,
  • Dionne A. Graham

      Affiliations

    • Clinical Research Program, Children's Hospital Boston, Boston, Massachusetts
    • ,
  • Caleb P. Nelson

      Affiliations

    • Department of Urology, Children's Hospital Boston, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Caleb P. Nelson, M.D., M.P.H., Department of Urology, Children's Hospital Boston, 300 Longwood Ave, HU-359, Boston, MA 02115

Received 25 August 2009 ,Accepted 27 October 2009.

References 

  1. Ashley R, Vandersteen D. Mini-ureteroneocystostomy: a safe and effective outpatient treatment for unilateral vesicoureteral reflux. J Urol. 2008;180:1621–1624
  2. Putman S, Wicher C, Wayment R, et al. Unilateral extravesical ureteral reimplantation in children performed on an outpatient basis. J Urol. 2005;174:1987–1989
  3. Anderson PD, Dewan PA. Catheter-less Cohen transtrigonal ureteric reimplantation. BJU Int. 2002;89:722–725
  4. Canon SJ, Jayanthi VR, Patel AS. Vesicoscopic cross-trigonal ureteral reimplantation: a minimally invasive option for repair of vesicoureteral reflux. J Urol. 2007;178:269–273
  5. Shu T, Cisek LJ, Moore RG. Laparoscopic extravesical reimplantation for postpubertal vesicoureteral reflux. J Endourol. 2004;18:441–446
  6. Casale P, Patel RP, Kolon TF. Nerve sparing robotic extravesical ureteral reimplantation. J Urol. 2008;179:1987–1989
  7. Peters CA, Woo R. Intravesical robotically assisted bilateral ureteral reimplantation. J Endourol. 2005;19:618–621
  8. Park JM, Houck CS, Sethna NF, et al. Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. Anesth Analg. 2000;91:11–15
  9. Gonzalez A, Smith DP. Minimizing hospital length of stay in children undergoing ureteroneocystostomy. Urology. 1998;52:501–504
  10. Miller OF, Bloom TL, Smith LJ, et al. Early hospital discharge for intravesical ureteroneocystostomy. J Urol. 2002;167:2556–2559
  11. Chauhan RD, Idom CB, Noe HN. Safety of ketorolac in the pediatric population after ureteroneocystostomy. J Urol. 2001;166:1873–1875
  12. Eberson CP, Pacicca DM, Ehrlich MG. The role of ketorolac in decreasing length of stay and narcotic complications in the postoperative pediatric orthopaedic patient. J Pediatr Orthop. 1999;19:688–692
  13. Lieh-Lai MW, Kauffman RE, Uy HG, et al. A randomized comparison of ketorolac tromethamine and morphine for postoperative analgesia in critically ill children. Crit Care Med. 1999;27:2786–2791
  14. Houck CS, Wilder RT, McDermott JS, et al. Safety of intravenous ketorolac therapy in children and cost savings with a unit dosing system. J Pediatr. 1996;129:292–296
  15. Duong DT, Parekh DJ, Pope JC, et al. Ureteroneocystostomy without urethral catheterization shortens hospital stay without compromising postoperative success. J Urol. 2003;170:1570–1573
  16. Flickinger JE, Trusler L, Brock JW. Clinical care pathway for the management of ureteroneocystostomy in the pediatric urology population. J Urol. 1997;158:1221–1225

 J.C. Routh is supported by grant number T32-HS000063 from the Agency for Healthcare Research and Quality.

PII: S0090-4295(09)02898-2

doi: 10.1016/j.urology.2009.10.062

Urology
Volume 76, Issue 1 , Pages 9-13 , July 2010

Article Tools